Head Neck Cancer

24 registered clinical trials studyying Head Neck Cancer — 9 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy NCT07405645	University of Virginia	N/A
Not Yet Recruiting	CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE) NCT07254962	Sir Mortimer B. Davis - Jewish General Hospital	Phase 2
Recruiting	Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer NCT06736379	VLP Therapeutics	Phase 1
Not Yet Recruiting	Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery NCT06530524	Sir Mortimer B. Davis - Jewish General Hospital	Phase 2
Recruiting	Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas NCT06642324	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	—
Completed	Evaluating Illustrated Vs. Traditional Pamphlets for Enhancing Self-Care in Radiation Therapy Patients NCT06678204	Chung Shan Medical University	N/A
Recruiting	Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. NCT05878964	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	—
Recruiting	Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer NCT05838729	Coordination Pharmaceuticals, Inc.	Phase 1 / Phase 2
Active Not Recruiting	A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectab NCT05572684	NextCure, Inc.	Phase 1 / Phase 2
Recruiting	First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients NCT04858269	Wake Forest University Health Sciences	Phase 2
Completed	Swallowing Function in Patients With Head and Neck Cancers NCT05833841	Banaras Hindu University	N/A
Unknown	Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer NCT04566367	Georg Dultz	N/A
Completed	Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer NCT03832686	Stanford University	N/A
Withdrawn	Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Pa NCT03747562	University Hospital, Ghent	Phase 3
Completed	Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC NCT03572829	Chinese Academy of Medical Sciences	Phase 2
Recruiting	Newer Therapeutic Targets in Head and Neck Cancers NCT05382585	Banaras Hindu University	—
Unknown	Calcium Electroporation for Head and Neck Cancer NCT03051269	Rigshospitalet, Denmark	Phase 1
Terminated	A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Mel NCT02521870	Dynavax Technologies Corporation	Phase 1 / Phase 2
Completed	Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissec NCT02268344	University of Alberta	N/A
Unknown	Electrochemotherapy on Head and Neck Cancer NCT02549742	Rigshospitalet, Denmark	Phase 2
Completed	Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy NCT02055833	Fondazione IRCCS Policlinico San Matteo di Pavia	N/A
Completed	Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors NCT01951664	Vanderbilt-Ingram Cancer Center	N/A
Completed	Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer NCT02075385	Barretos Cancer Hospital	Phase 2
Terminated	Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma NCT00198328	Inovio Pharmaceuticals	Phase 3